Outcomes
Yale Cancer Center and our partner, Smilow Cancer Hospital, acknowledge the seven American Society of Clinical Oncology (ASCO) and National Comprehensive Cancer Network (NCCN) evidence-based quality guidelines for breast and colorectal cancers. The latest performance data for colorectal cancer is listed below.
Colorectal Measures | Expected Estimated Performance Rates (percentage) | Yale Performance 2017 | Yale Performance 2018 | Yale Performance 2019 |
Adjuvant chemotherapy is recommended or administered within 4 months (120 days) of diagnosis for patients under the age of 80 with AJCC stage III (lymph node positive) colon cancer (Accountability) | N/A | 95.7 | 95.8 | 92.1 |
**Higher percentage is better